STAMFORD, Conn., Nov. 02, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Medifast, Inc. (NYSE: MED) (“Medifast” or the “Company”) on behalf of the Company’s investors. The investigation seeks to determine whether Medifast’s board of directors (the “Board”) has violated its fiduciary duty by instituting measures intended to interfere…Read More
INVESTOR ALERT Abbott Cooper PLLC Announces Investigation into Medifast Inc Urges Medifast Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
